These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2829625)

  • 1. Platelet alpha 2-adrenoceptor modifications induced by long-term treatment with indapamide in essential hypertension.
    Carretta R; Fabris B; Fischetti F; Muiesan S; Bardelli M; Melchior C; Cesanelli R; Pizzolitto A; Giraldi T; Greco PL
    Am J Med; 1988 Jan; 84(1B):31-5. PubMed ID: 2829625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indapamide versus hydrochlorothiazide in essential hypertension: measurement of peripheral resistance using plethysmography.
    Ogilvie R; Langlois S; Kreeft J
    Curr Med Res Opin; 1983; 8 Suppl 3():67. PubMed ID: 6352187
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma norepinephrine concentration and thrombocyte alpha 2-adrenoceptor density during long-term antihypertensive therapy with nitrendipine and captopril.
    Müller R; Steffen HM; Weller P; Kugel C; Freiheit T; Krone W
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):429-33. PubMed ID: 7528299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha 2-adrenergic receptors and arterial pressure].
    Senard JM; Valet P; Galinier M; Tran MA; Galinier F; Boneu B; Montastruc JL
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1139-41. PubMed ID: 2554834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indapamide versus beta-blocker therapy: a double-blind, crossover study in essential hypertension.
    Rumboldt Z; Rumboldt M; Jurisic M
    Curr Med Res Opin; 1984; 9(1):10-20. PubMed ID: 6373155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indapamide on the quality of life of hypertensive patients.
    Guez D; Crocq L; Safavian A; Labardens P
    Am J Med; 1988 Jan; 84(1B):53-8. PubMed ID: 3341388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians.
    Schaller MD; Waeber B; Brunner HR
    Clin Exp Hypertens A; 1985; 7(7):985-94. PubMed ID: 3899418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
    Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
    Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension.
    Spannbrucker N; Achhammer I; Metz P; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):190-3. PubMed ID: 3285833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of altered noradrenaline reactivity in essential hypertension by indapamide.
    Grimm M; Weidmann P; Meier A; Keusch G; Ziegler W; Glück Z; Beretta-Piccoli C
    Br Heart J; 1981 Oct; 46(4):404-9. PubMed ID: 7295437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered platelet alpha 2-adrenoceptors and adrenaline response in adolescents with borderline hypertension who have a family history of essential hypertension.
    Umemura S; Uchino K; Yasuda G; Ishikawa Y; Hatori Y; Tochikubo O; Ishii M; Kaneko Y
    J Hypertens Suppl; 1988 Dec; 6(4):S568-71. PubMed ID: 2853759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between arterial blood pressure disturbances and alpha adrenoceptor density.
    Galinier M; Senard JM; Valet P; Doazan JP; Durrieu G; Tran MA; Monstastruc JL; Bounhoure JP
    Clin Exp Hypertens; 1994 May; 16(3):373-89. PubMed ID: 8038761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril.
    Lacourciere Y
    Am J Med; 1988 Jan; 84(1B):47-52. PubMed ID: 3277419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension. Density of alpha 1 and alpha 2 adrenergic receptors in blood platelets, beta adrenergic receptors in the lymphocytes and serum catecholamine levels].
    Halawa B
    Kardiol Pol; 1991; 35(12):340-4. PubMed ID: 1666134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy in diabetic patients. The use of indapamide.
    Harrower AD; McFarlane G
    Am J Med; 1988 Jan; 84(1B):89-91. PubMed ID: 3277423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.